Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets.

Find the latest Absci Corporation (ABSI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Absci is a data-first generative AI drug creation company unlocking novel biology through generative AI. Our Integrated Drug Creation™ Platform powers cutting-edge de novo AI and lead optimization models aimed at designing better biologics against difficult-to-drug targets.

Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.

Get the latest Absci Corp (ABSI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Our pipeline demonstrates the capabilities of our AI drug creation platform, with a focus on cytokine biology. Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

2025年3月7日 · Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025. VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business u...